Awanish  Kumar

Department Bio Technology
Designation Assistant Professor
Educational Qualification Ph.D Biotechnology (CSIR-CDRI & JNU Delhi); PDF (McGill University, Canada)
E-Mail awanik.bt@nitrr.ac.in; drawanishkr@gmail.com
Contact Number 918871830586
Areas of Interest

Research Area: Antimicrobial Resistance, Drug Targeting, Drug Discovery, & Drug Delivery.

Publications

RESEARCH PUBLICATIONS

Papers in SCI Journals (A)

Papers in non-SCI referred Journal (B)

Complete Book (C)

Book Chapter

(D)

NCBI Gene Sequence (E)

Paper in Intentional/ National  Conference (F)

h-index

(G)

90

09

06

14

03

(30+27) =57

15

A). List of papers published in SCI/Scopus Journals: (in year wise descending order)                                Kumar A*= Awanish Kumar; *Corresponding Author 

90. Karn SK, Kumar A*  (2019). Preparative Biochem and Biotech; 49 (2): 105–116 (IF: 1.4, T&F)

89. Pandey SC, Jha A, Samant M, Kumar A* (2019). Int J of Biological Macromolecules; 121: 480-487 (IF: 3.9, Elsevier)

88. Nirala N, Singh BK, Periyasami R, Kumar A* (2019). Biocybernetics and Biomed Engg; 39 (1): 38-51. (IF: 1.4, Elsevier)

87. Jaiswal SK, Sharma NK, Krishnan S, Kumar A, Prakash O, Kumar P, Kumar A, Bharti SK (2019). Current Molecular Medicine; 18 (9): 640 – 653.  (IF: 2.2, Bentham)

86. Sharma A, Gudala S, Ambati SR, Payra S, Raza A, Aruna LV, Vedula RR,  Jha A, Kumar A, Penta S, Banerjee S (2019). Chemistry Select; 3 (39): 11012-19 (IF: 1.5, Wiley)

85. Nirala N, Periyasami R, Kumar A* (2018). Annals of Vascular Surgery; 52(10): 263-272. (IF: 1.2, Elsevier)

84. Thakur P, Kumar A, Kumar A* (2018). J Drug Targeting; 26 (9): 766-776. (IF: 3.1, T&F).

83. Srivastava A, Kumar S, Kumar A* (2018). Biomedicine & Pharmacotherapy;105; 256-266. (IF: 2.8, Elsevier)

82. Verma S, Kumar A, Tripathi T, Kumar A* (2018). J Pharmacy Pharmacology;70(8):985-993. (IF: 2.3, Wiley)

81. Shukla R, Shukla H, Kalita P, Sonkar A, Pandey T, Singh DB, Kumar A, Tripathi T (2018). J Biomol Struct Dyn; 36 (8): 2045-2057. (IF: 3.2, T&F)

80. Sharma A, Satish S, Ambatia SR, Penta S, Bomma Y, Janapala VR, Jha A, Kumar A (2018).  J Chinese Chem Society; 65 (7):810-821. (IF: 2.2, Wiley)

79. Sinha A, Nishant N, Kumar A* (2018). Mathematical Biosciences; 301: 37-49. (IF: 1.5, Elsevier)

78. Nirala N, Periyasami R, Kumar A* (2018). Int J Bioinfo Res and Applications; 14(3):283-304 (Scopus)

77. Vimal A, Kumar A* (2018). 3 Biotech; 8(6) 278. (IF: 1.5, Springer)

76. Satish G, Sharma A, Rao VR, Kumar A, Penta S (2018).  Chemical Papers; 72 (5) 1065–1080.

75. Rajendran V, Kalita P, Shukla H, Kumar A,  Tripathi T (2018).  Int J of Biological Macromol; 111:400-414 (IF: 3.7, Elsevier)

74. Bharti SK, Krishnan S, Kumar A, Kumar A*(2018).  Therapeutic Adv in Endocrin & Metabol; 9(3) 81–100. (3.9, Sage)

 73. Kumar A, Pandey SC, Samant M (2018). Slow pace of antileishmanial drug development. Parasitology Open; 4, e4, 1–11. (Scopus)

 72. Jha A, Kumar A* (2018). Int J of Biological Macromol;107(A): 1212-1219. (IF: 3.9, Elsevier)

71. Kumar A, Pal D* (2018). J of Environmental Chemical Engg; 6 (1): 52-58. (IF: 2.4, Elsevier)

70. Vimal A, Jha A, Kumar A* (2018). Microbial Pathogenesis; 114: 8-16. (IF: 2.3, Elsevier)

69. Behera SS, Panda SH, Mohapatra S, Kumar A* (2018). LWT-Food Science & Technology; 87:342-350. (IF: 3.2, Elsevier)

68. Vimal A, Kumar A* (2018). Letters in Drug Design & Discovery; 14(12):1433-1454 (IF: 1.0, Bentham)

67. Pal D, Kumar A, Keshav A, Majumdar B (2017). J of Institution of Engineers (India): Series E; 98(2):165-75 (Scopus, Springer)

66. Srivastava A, Gupta J, Kumar S, Kumar A* (2017). Microbial Pathog; 112: 5-14. (IF: 2.3, Elsevier)

65. Bit A¥, Kumar A¥, Singh AK, Rizvanov AA, Kiassov AP, Patra PK, Kumar M and Bissoyi A (2017). Stem Cells Int; Vol. 17,Article ID 1380304, 9 pages. (IF: 3.9, Hindawi)    

64.  Kumar A, Bharti SK, Kumar A* (2017). Pharmacological Reports; 69 (5): 959–970. (IF: 2.8, Elsevier)    

63. Thakur P, Kumar A, Patra PK, Kumar A* (2017). Advances in Human Biology; 7(3):124-129. (ESSI, WC)

62. Kumar S, Gupta J, Mohan A, Kumar A* (2017). J Pharmacovig  Pharmacotherapeutics; 02:1-6 (Scopus)

61. Panigrahy SK, Kumar A*, Bhatt R (2017). J of Food Science & Technology; 54(10):3297–3306. (IF: 1.8, Springer).

 60. Karn  SK,  Eswari SJ, Rajput VD, Rana S,  Kumar A* (2017). Envt Engineering Science; 34(8):551-561. (IF: 1.5, MAnnL) 

59. Vimal A, Kumar A* (2017). Biotechnology and Genetic Engg Rev; 33(1):40-61. (IF: 1.7, T&F)

58. Vimal A, Pal D, Tripathi T, Kumar A* (2017). 3 Biotech; 7(4):258. (IF: 1.5, Elsevier)

57. Athanerey A, Patra PK, Kumar A* (2017). Journal of Tissue Viability; 26(3):216-223 (IF: 1.9, Elsevier)

56. Pal D,  Keshav A, Thakre N, Kumar A, Singh D (2017). Brazilian J Chem Engg (IF: 1.1, Brazilian Chem Soc)

55. Singh AK, Jha A, Bit A, Kiyasov A, Rizvanov AA, Bhoi P, Patra PK, Kumar A*, Bissoyi A* (2017). Oxidative Medicine and Cellular Longevity (IF: 4.9, Hindawi)

54. Vimal A, Kumar A* (2017). Drug Discovery Today; 22 (5): 814-822 (IF: 6.84, Elsevier)

53. Behera S, Das U, Kumar A, Bissoyi A, Singh AK (2017). Int J Biol Macromol; 98: 323-343(IF: 3.9, Els).

52. Kumar A, Kumar A* (2017). Materials Science and Engineering: C; 73: 333–339. (IF: 5.1, Elsevier).

51. Vimal A, Kumar A*(2017). Enzyme and Microbial Technol; 98:9-17 (IF: 2.9, Elsevier).

50. Kumar S, Shukla R, Ranjan P, Kumar A* (2017). Clinical Theraputics; 39 (3) 632-643 (IF: 3.2, Elsevier)

49. Panigrahy SK, Bhatt R, Kumar A* (2017). J Drug Targeting; 25 (2); 93-101. (IF: 3.4, T&F)

48. Chaturvedi AD, Pal D, Kumar A*(2017). Biochemistry & Analytical Biochm; 6 (1) 1-4. (Scopus)

47. Sinha AK,  Singh P,  Prakash A, Pal D, Dube A, Kumar A* (2017). IEEE/ACM Transactions on Comp Biology and Bioinformatics; 14 (1) 204-211 (IF: 1.9, IEEE).

46. Kumar A* and Pal D (2016). Academic Journal of Science, 06(01):123–130. (Scopus, UPC)

45. Kumar A, Nayak BP, Kumar A* (2016). Minerva Endocrinol; 41(4):499-508.  (IF: 1.2, Minerva Medica).

44. Pandey AK, Sarada DVL, Kumar A* (2016). PNAS, India Sec B: Biol Sci; 86(4):805–815. (IF: 0.4, Springer).

43. Jha A, Kumar A* (2016).  J of Mol Graphics & Modelling; 69:1-7. (IF: 1.8, Elsevier)

42. Vimal A, Eswari JS, Kumar A* (2016). Int J of Pharmacy & Pharma Sci; 8(7)420-426. (IF: 0.5, Innova)

41. Bissoyi A¥, Kumar A¥, Rizvanov A, Nesmelov A, Gusev O, Patra PK, Bit A (2016). Stem Cells International; Article ID 3604203, 9 pages. (3.9, Hindawi)

40. Thakre N, Prajapati, A, Mahapatra, S, Kumar A; Khapre  A,  Pal D (2016). J of Chemical & Engineering Data; 61 (7), 2614–2623. (IF: 2.2, ACS)

39. Kumar A, Vimal A, Kumar A* (2016). Int J of Biol Macromolecules; 91; 615-622. (IF: 3.90, Elsevier)

38. Vimal A, Kumar A* (2016). Pharmacological Research; 111:101. (IF: 4.9, Elsevier)

37. Kumar A, Samant M (2016). Parasite Immunol; 38(5):273-81. (IF: 2.8, Wiley)

36. Nisha CM, Kumar A, Nair P, Gupta N, Silakari C, Tripathi T, Kumar A* (2016). Advances in Bioinformatics; Article ID 9258578, 1-6. (Scopus, Hindawi)

35. Nisha CM, Kumar A, Vimal A, Bai BM, Pal D, Kumar A* (2016). J of Mol Graphics & Modelling; 65;  100–107. (IF: 1.8, Elsevier)

34. Bharti SK,   Krishnan S, Kumar  A* (2016). Minerva Endocrinol; 41(1):143-146. (IF: 1.2, Minerva Medica)

33. Pal D, Thakre N, Kumar A, & Keshav A (2016). Separation Science &  Tech; 51(7): 1141-1150. (IF: 1.10, T&F)

32. Kumar A, Nisha CM, Silakari C, Sharma I, Gupta N, Nair P, Kumar A* (2016). J Formos Med Assoc; 115;3-10. (IF: 2.5, Elsevier)

31. Chaturvedi AD, Pal D, Penta S, Kumar A* (2015). World J Microbiol Biotechnol; 31(10):1595-1603. (IF: 2.1, Springer)

30. Karn SK and Kumar A* (2015). Biotechnology  Bioprocess Eng; 17(5):923-931. (IF: 1.2, Springer)

 29. Bharti SK, Krishnan S, NK Sharma, Kumar A, Prakash O, Gupta AK, Kumar A* (2015). Current Hypertension Rev; 11(2):143-158. (Scopus, Bentham)

 28. Kumar A, Samant M, Misra P,  Khare P, Sundar S, Garg R, Dube A (2015). Parasite Immunol; 37(7):368-375. (IF: 2.8, Wiley)

27. Chhetri G, Pandey T, Chinta R, Kumar A*, Tripathi T (2015). Protein Express & Purification; 114:71-76. (IF: 1.3, Elsevier)

26. Kumar A, Parasitology International; 64(4) 36-42. (IF: 2.2, Elsevier)

25. Bharti SK,  Kumar A, Krishnan S, Gupta AK, Kumar  A* (2015). Process Biochem; 50, 317-327. (IF: 2.6, Elsevier)

24. Gopal GJ, Pal J, Kumar A, Mukhopadhyay G (2015). Biochem Biophys Res Commun; 464(1):98-103. (IF: 2.5, Elsevier)

23. Mishra PK, Sinha A, Teja KR, Bhojwani N, Sahu S, Kumar A* (2014). Bioinformation; 30;10(9):556-561. (Scopus)

22. Kumar A, Bharti SK, Kumar A* (2014). Apollo Medicine; 1 (9): 161-166. (Scopus, Elsevier)

21. Tandon R, Chandra S, Baharia RK, Das S, Misra P, Kumar A, Siddiqi MI, Sundar S, Dube A (2014). Antimicrob Agents Chemother; 58(6):2997-3007. (IF: 4.8, ASM)

20. Gopal GJ, Kumar A, Pal J, Mukhopadhyay G (2014). Bioengineered; 5(2), 107–113. (IF: 1.6, Taylor & Francis)

19. Pandey AK, Kumar A* (2014). Process Biochem; 49, 496–505. (IF: 2.6, Elsevier)

18. Kumar A, Misra P, Sisodia B, Shasany AK, Sundar S, Dube A (2014) Pathog Dis 70(1):84-87. (IF: 2.5, Wiley)

17. Kumar A, Dhamgaye S, Maurya IK, Singh A, Sharma M, Prasad R (2014). Antimicrob Agents Chemother; 58(1):167-175. (IF: 4.8, ASM)

16. Bharti SK, Kumar A, Sharma NK, Prakash O, Jaiswal SK, Krishnan S, Gupta AK, Kumar A* (2013). J Formos Med Assoc; 112 (11), 676-690. (IF: 2.5, Elsevier)

15. Gopal GJ, Kumar A* (2013). Protein J; 32(6):419-425. (IF: 1.2, Springer)

14.Yadav J, Kumar A, Mahorm P, Goel AK, Yadava PK, Kumar P (2013). J Formos Med Assoc.13;1-8.(IF: 2.5, Elsevier)

13. Kumar A, Misra P, Dube A (2013). Para Res;112 (2):457-466. (IF: 2.5, Springer)

12. Kumar A, Sisodia B, Misra P, Sundar S, Shasany AK, Dube A (2010). British J of Clinical Pharmacology; 70(4):609-617. (IF: 3.8, Wiley)

11. Misra P, Sashidhara KV, Singh SP, Kumar A, Chaudhaery SS, Gupta SS, Majumder HK, Saxena AK, Dube A (2010). British J. of Pharmacology; 159, 1143-1150. (IF: 6.8, Wiley)

10. Kumar A, Boggula VR, Misra P, Sundar S, Shasany AK, and Dube A (2010). Acta Tropica; 113(2):202-206. (IF: 2.5, Elsevier)

09. Kumar A, Sen A, Das P (2010). Int J Adv in Pharma Sci; 1(1):01-14. (Scopus)

08. Sashidhara KV, Singh SP, Misra P, Kumar A, Majumder HK, Saxena AK, Dube A (2010. Medicinal Chem Res (Procd ISCBC-2010);19,S144-S145.(IF:1.6, Springer)

07. Misra P, Kumar A, Khare P, Kumar N, Dube A (2009). J Med Microbio;58:1058-1066.(IF: 2.5, MSR)

06. Kumar A, Boggula VR, Sundar S, Shasany AK, and Dube A (2009). Acta Tropica; 110(1):80-85. (IF: 2.5, Elsevier)

05. Kumari S, Kumar A, Samant M, Singh N, Dube A (2008). Cur Drug Target; 9(11):938-947. (IF: 3.1, Bentham)

04. Misra P,  Khaliq T,  Dixit A,  Samant M, Kumari S, Kumar A, Majumder HK,  Saxena AK, Narender T, Dube A (2008). J of Antimicrobial Chemotherapy; 62:998-1002. (IF: 5.2, Oxford)

03. Kumari S, Kumar A, Samant M, Sundar S, Dube A (2008). Proteomics clin Appl;2(3):372-386. (IF: 3.9, Wiley)

02. Singh N, Kumar A, Gupta P, Maurya R, Dube A (2008). Para Res.;102:561-565. (IF: 2.5, Springer)

01. Singh N, Samant M, Gupta SK, Kumar A, Dube A (2007). Para Res; 101:919-924. (IF: 2.5, Springer)

Other Info.

POSITIONS HELD 

  • 2013–Present  :  Asstt. Professor, National Institute of Technology (NIT), Raipur, India     
  • 2011–2013      :  Postdoctoral Fellow, Jawaharlal Nehru University (JNU), New Delhi, India
  • 2009-2010       :  Postdoctoral Fellow, McGill University (MGU), Montreal, Canada
  • 2008-2009       :  Lecturer, National Institute of Pharma Edu & Research (NIPER), Hajipur, India 

 RESEARCH SUPERVISION

  • Ph.D.   : 03 (Completed), 03 (On-going). 
  • PG        : 06 (Completed). 
  • UG        : 33 (Completed), 7 (On-going).

SPONSORED RESEARCH PROJECTS 

SN

Funding Agency

Role

Status

3

DBT (Indo-USA grant)

PI

Ongoing

2

CCOST (Mini research grant)

PI

Completed

1

UGC (Early career grant)

PI

Completed

RESEARCH GRANT PROPOSALS REVIEWED: 1. National Science Center (NSC), Poland; 2. Departments of Science & Technology (DST), India.

RESEARCH PAPERS REVIEWED: 91 research papers from different SCI journals

EXTERNAL EXAMINER/REVIEWER FOR Ph.D. THESIS: 04

CONFERENCES/WORKSHOPS ORGANIZED: 06

CURRICULUM/SYLLABUS DESIGNED: For many institute/universities.

COURSES TAUGHT

  • UG level: 1. Animal Biotechnology, 2. Analytical Techniques, 3. Biophysics, 4. Biosafety and Bioethics, 5. Cell & Molecular Biology, 6. Genomics, 7. Plant Biotechnology, 8. RDT.
  • PG level: 1. Biochemistry, 2. Cell Biology, 3. Microbiology, 4. Molecular Biology, 5. Proteomics. 
  • Ph.D. level: 1. Biochemistry, 2. Bio-instrumentation, 3. Enzyme Technology

AWARDS/SCHOLARSHIPS

  1. Young Scientist/research investigator award from UGC, New Delhi, India: 2011
  2. Excellent research award from CSIR- CDRI, Lucknow, India: 2011
  3. Postdoctoral Fellowship from Canadian Institute of Health Research (CIHR), Canada : 2009
  4. Senior Research Fellowship from CSIR-UGC (Govt. of India), New Delhi (India) for Ph.D. : 2007
  5. Junior Research Fellowship from CSIR-UGC (Govt. of India), New Delhi, (India) for Ph.D. : 2005
  6. Awarded National Eligibility (NET) for Lectureship with JRF from CSIR-UGC, New Delhi, India : 2004 & 2005
  7. Awarded Junior Research Fellowship (JRF) from Dept. of Biotechnology, New Delhi, India: 2004
  8. National Merit Scholarship for PG from Department of Biotechnology, Govt. of India, New Delhi, India : 2002

INTERNATIONAL AND NATIONAL HONOURS

  • 2015-Present: Member; Massive Open Online Courses (MOOCs) of MHRD, NIT Raipur
  • 2014-2016: Member Secretary, Institutional Ethical Committee (IEC), NIT, Raipur.
  • 2013-Present: Member, Global Foodborne Infections Network, Centre for Disease Control (CDC), USA.
  • 2013-Present: Advisor, Bioinfo-Drug Target, USA.

ADMINISTRATIBE CONTRIBUTION

  • 2014-Present: Member, Departmental Academic, Purchase, Doctoral Research committee of NIT, Raipur.
  • 2013-Present: Member; Institutional Anti Ragging committee, NIT, Raipur.
  • 2013-2015    : Member, Task force, Industry Institute Interaction (III) Cell, NIT Raipur
  • 2008-2009   : Member; Examination Board Moderation Committee, Library Committee, Institutional Purchase Committee, Scientific Review Committee of NIPER, Hajipur.